Literature DB >> 6324266

Cortisol, 11-deoxycortisol, and ACTH concentrations after dexamethasone in depressed patients and healthy volunteers.

F Holsboer, H G Doerr, A Gerken, O A Müller, W G Sippell.   

Abstract

The 1 mg dexamethasone suppression test was used to assess pituitary-adrenal activity in 23 depressed patients and 8 healthy volunteers. At 1600h, after administration of the test dose of dexamethasone at 2300h, levels of cortisol, 11-deoxycortisol, and corticotropin were determined following a chromatographic extraction step applying highly specific radioimmunoassay techniques. Cortisol nonsuppressors had significantly increased adrenocorticotropic hormone (ACTH) values and cortisol/11-deoxycortisol ratios. The cortisol/11-deoxycortisol ratio was regarded as a measure of biologically active ACTH. The present results, which indicate a concordance of corticotropin and corticosteroid response, suggest that the parent abnormality of dexamethasone-resistant cortisol concentrations is elevation of biologically active corticotropin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6324266     DOI: 10.1016/0165-1781(84)90104-5

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  3 in total

Review 1.  Psychoneuroendocrine research in depression. I. Hormone levels of different neuroendocrine axes and the dexamethasone suppression test.

Authors:  R Rupprecht; K P Lesch
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

2.  The adrenal steroid profile in adolescent depression: a valuable bio-readout?

Authors:  Raphael Hirtz; Lars Libuda; Anke Hinney; Manuel Föcker; Judith Bühlmeier; Paul-Martin Holterhus; Alexandra Kulle; Cordula Kiewert; Berthold P Hauffa; Johannes Hebebrand; Corinna Grasemann
Journal:  Transl Psychiatry       Date:  2022-06-18       Impact factor: 7.989

3.  Acth and the dexamethasone suppression test in depression.

Authors:  A K Jainer; M Sharma; J K Trivedt; C G Agarwal; S C Tiwari
Journal:  Indian J Psychiatry       Date:  1992-01       Impact factor: 1.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.